https://www.wikonsult.org/index.php?action=history&feed=atom&title=Anticoagulant_oral_direct 2026-10-23T02:59:59Z Historique des révisions pour cette page sur le wiki MediaWiki 1.34.1 https://www.wikonsult.org/index.php?title=Anticoagulant_oral_direct&diff=7163&oldid=prev 2025-12-30T11:09:35Z

<p>warfarine 2015.. ça a changé en 2024</p> <table class="diff diff-contentalign-left" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="fr"> <td colspan="2" style="background-color: #fff; color: #222; text-align: center;">← Version précédente</td> <td colspan="2" style="background-color: #fff; color: #222; text-align: center;">Version du 30 décembre 2025 à 11:09</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l24" >Ligne 24 :</td> <td colspan="2" class="diff-lineno">Ligne 24 :</td></tr> <tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>* [[AVK]]</div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>* [[AVK]]</div></td></tr> <tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td></tr> <tr><td class='diff-marker'>−</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>* Apixaban - Eliquis°. Thrombose veineuse profonde ou embolie pulmonaire : la warfarine <del class="diffchange diffchange-inline">reste </del>la référence; Rev Prescrire 2015 ; 35 (379) : 330 http://www.prescrire.org/Fr/B5AC66ACF31B8D98E793D1B276CAC1DA/Download.aspx$</div></td><td class='diff-marker'>+</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>* Apixaban - Eliquis°. Thrombose veineuse profonde ou embolie pulmonaire : la warfarine <ins class="diffchange diffchange-inline">était encore </ins>la référence <ins class="diffchange diffchange-inline">en 2015</ins>; Rev Prescrire 2015 ; 35 (379) : 330 http://www.prescrire.org/Fr/B5AC66ACF31B8D98E793D1B276CAC1DA/Download.aspx$</div></td></tr> <tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>* Xabans : principales situations risque accru hémorragique : age, [[IR]] : Cockroft et CKD : retenir le plus bas(p519 7/20), ou hépatique, [[IMC]]&lt;18,5, [[w:fr:interaction médicamenteuse]] : prescrire 7/20 p506 https://www.prescrire.org/Fr/FE7DEE9222C1A0631C73DA95B1C765AD/Download.aspx</div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>* Xabans : principales situations risque accru hémorragique : age, [[IR]] : Cockroft et CKD : retenir le plus bas(p519 7/20), ou hépatique, [[IMC]]&lt;18,5, [[w:fr:interaction médicamenteuse]] : prescrire 7/20 p506 https://www.prescrire.org/Fr/FE7DEE9222C1A0631C73DA95B1C765AD/Download.aspx</div></td></tr> <tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td></tr> </table>

Yves.bertin https://www.wikonsult.org/index.php?title=Anticoagulant_oral_direct&diff=6338&oldid=prev 2020-07-21T20:02:36Z

<p></p> <table class="diff diff-contentalign-left" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="fr"> <td colspan="2" style="background-color: #fff; color: #222; text-align: center;">← Version précédente</td> <td colspan="2" style="background-color: #fff; color: #222; text-align: center;">Version du 21 juillet 2020 à 20:02</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l27" >Ligne 27 :</td> <td colspan="2" class="diff-lineno">Ligne 27 :</td></tr> <tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>* Xabans : principales situations risque accru hémorragique : age, [[IR]] : Cockroft et CKD : retenir le plus bas(p519 7/20), ou hépatique, [[IMC]]&lt;18,5, [[w:fr:interaction médicamenteuse]] : prescrire 7/20 p506 https://www.prescrire.org/Fr/FE7DEE9222C1A0631C73DA95B1C765AD/Download.aspx</div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>* Xabans : principales situations risque accru hémorragique : age, [[IR]] : Cockroft et CKD : retenir le plus bas(p519 7/20), ou hépatique, [[IMC]]&lt;18,5, [[w:fr:interaction médicamenteuse]] : prescrire 7/20 p506 https://www.prescrire.org/Fr/FE7DEE9222C1A0631C73DA95B1C765AD/Download.aspx</div></td></tr> <tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td></tr> <tr><td class='diff-marker'>−</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>* https://www.ebmfrance.net/fr/Pages/ebm/ebm01147.aspx : [[<del class="diffchange diffchange-inline">EBMFrance</del>]] 2017</div></td><td class='diff-marker'>+</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>* https://www.ebmfrance.net/fr/Pages/ebm/ebm01147.aspx : [[<ins class="diffchange diffchange-inline">EBMfrance</ins>]] 2017</div></td></tr> <tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td></tr> <tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>* Info Patient : 3/19 : https://www.prescrire.org/Fr/770A6905B7A43954FDC482DD2EDEFBDB/ViewClipping.aspx</div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>* Info Patient : 3/19 : https://www.prescrire.org/Fr/770A6905B7A43954FDC482DD2EDEFBDB/ViewClipping.aspx</div></td></tr> </table>

Yves.bertin https://www.wikonsult.org/index.php?title=Anticoagulant_oral_direct&diff=6337&oldid=prev 2020-07-21T20:01:47Z

<p><span dir="auto"><span class="autocomment">Voir</span></span></p> <table class="diff diff-contentalign-left" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="fr"> <td colspan="2" style="background-color: #fff; color: #222; text-align: center;">← Version précédente</td> <td colspan="2" style="background-color: #fff; color: #222; text-align: center;">Version du 21 juillet 2020 à 20:01</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l26" >Ligne 26 :</td> <td colspan="2" class="diff-lineno">Ligne 26 :</td></tr> <tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>* Apixaban - Eliquis°. Thrombose veineuse profonde ou embolie pulmonaire : la warfarine reste la référence; Rev Prescrire 2015 ; 35 (379) : 330 http://www.prescrire.org/Fr/B5AC66ACF31B8D98E793D1B276CAC1DA/Download.aspx$</div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>* Apixaban - Eliquis°. Thrombose veineuse profonde ou embolie pulmonaire : la warfarine reste la référence; Rev Prescrire 2015 ; 35 (379) : 330 http://www.prescrire.org/Fr/B5AC66ACF31B8D98E793D1B276CAC1DA/Download.aspx$</div></td></tr> <tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>* Xabans : principales situations risque accru hémorragique : age, [[IR]] : Cockroft et CKD : retenir le plus bas(p519 7/20), ou hépatique, [[IMC]]&lt;18,5, [[w:fr:interaction médicamenteuse]] : prescrire 7/20 p506 https://www.prescrire.org/Fr/FE7DEE9222C1A0631C73DA95B1C765AD/Download.aspx</div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>* Xabans : principales situations risque accru hémorragique : age, [[IR]] : Cockroft et CKD : retenir le plus bas(p519 7/20), ou hépatique, [[IMC]]&lt;18,5, [[w:fr:interaction médicamenteuse]] : prescrire 7/20 p506 https://www.prescrire.org/Fr/FE7DEE9222C1A0631C73DA95B1C765AD/Download.aspx</div></td></tr> <tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;"></ins></div></td></tr> <tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">* https://www.ebmfrance.net/fr/Pages/ebm/ebm01147.aspx : [[EBMFrance]] 2017</ins></div></td></tr> <tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td></tr> <tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>* Info Patient : 3/19 : https://www.prescrire.org/Fr/770A6905B7A43954FDC482DD2EDEFBDB/ViewClipping.aspx</div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>* Info Patient : 3/19 : https://www.prescrire.org/Fr/770A6905B7A43954FDC482DD2EDEFBDB/ViewClipping.aspx</div></td></tr> </table>

Yves.bertin https://www.wikonsult.org/index.php?title=Anticoagulant_oral_direct&diff=6205&oldid=prev 2020-07-01T13:45:20Z

<p>Cockroft et CKD : retenir le plus bas(p519 7/20)</p> <table class="diff diff-contentalign-left" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="fr"> <td colspan="2" style="background-color: #fff; color: #222; text-align: center;">← Version précédente</td> <td colspan="2" style="background-color: #fff; color: #222; text-align: center;">Version du 1 juillet 2020 à 13:45</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l25" >Ligne 25 :</td> <td colspan="2" class="diff-lineno">Ligne 25 :</td></tr> <tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td></tr> <tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>* Apixaban - Eliquis°. Thrombose veineuse profonde ou embolie pulmonaire : la warfarine reste la référence; Rev Prescrire 2015 ; 35 (379) : 330 http://www.prescrire.org/Fr/B5AC66ACF31B8D98E793D1B276CAC1DA/Download.aspx$</div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>* Apixaban - Eliquis°. Thrombose veineuse profonde ou embolie pulmonaire : la warfarine reste la référence; Rev Prescrire 2015 ; 35 (379) : 330 http://www.prescrire.org/Fr/B5AC66ACF31B8D98E793D1B276CAC1DA/Download.aspx$</div></td></tr> <tr><td class='diff-marker'>−</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>* Xabans : principales situations risque accru hémorragique : age, [[IR]] ou hépatique, [[IMC]]&lt;18,5, [[w:fr:interaction médicamenteuse]] : prescrire 7/20 p506 https://www.prescrire.org/Fr/FE7DEE9222C1A0631C73DA95B1C765AD/Download.aspx</div></td><td class='diff-marker'>+</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>* Xabans : principales situations risque accru hémorragique : age, [[IR]] <ins class="diffchange diffchange-inline">: Cockroft et CKD : retenir le plus bas(p519 7/20), </ins>ou hépatique, [[IMC]]&lt;18,5, [[w:fr:interaction médicamenteuse]] : prescrire 7/20 p506 https://www.prescrire.org/Fr/FE7DEE9222C1A0631C73DA95B1C765AD/Download.aspx</div></td></tr> <tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td></tr> <tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>* Info Patient : 3/19 : https://www.prescrire.org/Fr/770A6905B7A43954FDC482DD2EDEFBDB/ViewClipping.aspx</div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>* Info Patient : 3/19 : https://www.prescrire.org/Fr/770A6905B7A43954FDC482DD2EDEFBDB/ViewClipping.aspx</div></td></tr> </table>

Yves.bertin https://www.wikonsult.org/index.php?title=Anticoagulant_oral_direct&diff=6195&oldid=prev 2020-07-01T12:57:33Z

<p>situations risque</p> <table class="diff diff-contentalign-left" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="fr"> <td colspan="2" style="background-color: #fff; color: #222; text-align: center;">← Version précédente</td> <td colspan="2" style="background-color: #fff; color: #222; text-align: center;">Version du 1 juillet 2020 à 12:57</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l24" >Ligne 24 :</td> <td colspan="2" class="diff-lineno">Ligne 24 :</td></tr> <tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>* [[AVK]]</div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>* [[AVK]]</div></td></tr> <tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td></tr> <tr><td class='diff-marker'>−</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>* Apixaban - Eliquis°. Thrombose veineuse profonde ou embolie pulmonaire : la warfarine reste la référence</div></td><td class='diff-marker'>+</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>* Apixaban - Eliquis°. Thrombose veineuse profonde ou embolie pulmonaire : la warfarine reste la référence<ins class="diffchange diffchange-inline">; </ins>Rev Prescrire 2015 ; 35 (379) : 330 http://www.prescrire.org/Fr/B5AC66ACF31B8D98E793D1B276CAC1DA/Download.aspx$</div></td></tr> <tr><td class='diff-marker'>−</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>Rev Prescrire 2015 ; 35 (379) : 330 <del class="diffchange diffchange-inline">  </del>http://www.prescrire.org/Fr/B5AC66ACF31B8D98E793D1B276CAC1DA/Download.aspx$</div></td><td class='diff-marker'>+</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins class="diffchange diffchange-inline">* Xabans : principales situations risque accru hémorragique : age, [[IR]] ou hépatique, [[IMC]]&lt;18,5, [[w:fr:interaction médicamenteuse]] : prescrire 7/20 p506 https://www.prescrire.org/Fr/FE7DEE9222C1A0631C73DA95B1C765AD/Download.aspx</ins></div></td></tr> <tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div> </div></td></tr> <tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins class="diffchange diffchange-inline">* Info Patient : 3/19 : https://www.prescrire.org/Fr/770A6905B7A43954FDC482DD2EDEFBDB/ViewClipping.aspx</ins></div></td></tr> <tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td></tr> <tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>== ANtidote ==</div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>== ANtidote ==</div></td></tr> </table>

Yves.bertin https://www.wikonsult.org/index.php?title=Anticoagulant_oral_direct&diff=2600&oldid=prev 2019-02-24T14:41:33Z

<p>1 révision importée</p> <table class="diff diff-contentalign-left" data-mw="interface"> <tr class="diff-title" lang="fr"> <td colspan="1" style="background-color: #fff; color: #222; text-align: center;">← Version précédente</td> <td colspan="1" style="background-color: #fff; color: #222; text-align: center;">Version du 24 février 2019 à 14:41</td> </tr><tr><td colspan="2" class="diff-notice" lang="fr"><div class="mw-diff-empty">(Aucune différence)</div> </td></tr></table>

Yves.bertin https://www.wikonsult.org/index.php?title=Anticoagulant_oral_direct&diff=2599&oldid=prev 2019-01-02T13:32:53Z

<p>Page créée avec « Fichier:1tap.jpg|redresse=1.25|vignette|Anticoagulant oral direct d&#039;&#039;&#039;{{Lien|trad=Ornithodoros moubata|lang=en|fr=Ornithodoros moubata}}&#039;&#039; ({{PDB|1TAP}}&lt;ref name=&quot;10.101... »</p> <p><b>Nouvelle page</b></p><div>[[Fichier:1tap.jpg|redresse=1.25|vignette|Anticoagulant oral direct d'''{{Lien|trad=Ornithodoros moubata|lang=en|fr=Ornithodoros moubata}}'' ({{PDB|1TAP}}&lt;ref name=&quot;10.1016/0014-5793(94)00941-4&quot;&gt;<br /> {{Article<br /> | langue = en<br /> | nom1 = W. Antuch, P. Güntert, M. Billeter, T. Hawthorne, H. Grossenbacher et K. Wüthrich<br /> | titre = NMR solution structure of the recombinant tick anticoagulant protein (rTAP), a factor Xa inhibitor from the tick ''Ornithodoros moubata''<br /> | périodique = FEBS Letters<br /> | volume = 352<br /> | numéro = 2<br /> | jour = 26<br /> | mois = septembre<br /> | année = 1994<br /> | pages = 251-257<br /> | url texte = http://www.sciencedirect.com/science/article/pii/0014579394009414<br /> | consulté le = 12 juillet 2016<br /> | doi = 10.1016/0014-5793(94)00941-4<br /> | pmid = 7925983<br /> | pmc = <br /> }}&lt;/ref&gt;).]]<br /> <br /> Les '''anticoagulants oraux directs''' ('''[[AOD]]''', antérieurement appelés '''nouveaux anticoagulant oraux''' ou '''[[NACO]]'''&lt;ref&gt;Gilles Bouvenot, Jean-Paul Bounhoure, Jean-Louis Montastruc, André Vacheron au nom de la Commission II de l'Académie Nationale de Médecine, {{pdf}} [http://www.academie-medecine.fr/wp-content/uploads/2014/06/aod2805.pdf ''Rapport sur les anticoagulants oraux directs (AOD) (antérieurement appelés « nouveaux anticoagulants oraux » ou NACO)''], 2014&lt;/ref&gt;) sont des [[wp:fr:anticoagulant oral|anticoagulants pris par voie orale]].<br /> <br /> == Voir==<br /> * [[wp:fr:AOD]]<br /> * [[AVK]]<br /> <br /> * Apixaban - Eliquis°. Thrombose veineuse profonde ou embolie pulmonaire : la warfarine reste la référence<br /> Rev Prescrire 2015 ; 35 (379) : 330 http://www.prescrire.org/Fr/B5AC66ACF31B8D98E793D1B276CAC1DA/Download.aspx$<br /> <br /> == ANtidote ==<br /> * Idarucizumab - Praxbind°. Ne pas trop compter dessus comme antidote du dabigatran<br /> Rev Prescrire 2016 ; 36 (393) : 494-499 http://www.prescrire.org/Fr/861693870D316C733E60F9E49CA98FD6/Download.aspx<br /> <br /> [[Catégorie:cardio]]<br /> [[Catégorie:thérapeutique]]</div>

Yves.bertin